151 related articles for article (PubMed ID: 23238634)
1. Establishment of a survival and toxic cellular model for Parkinson's disease from chicken mesencephalon.
Tolosa A; Zhou X; Spittau B; Krieglstein K
Neurotox Res; 2013 Aug; 24(2):119-29. PubMed ID: 23238634
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effects of pyrroloquinoline quinone against rotenone injury in primary cultured midbrain neurons and in a rat model of Parkinson's disease.
Zhang Q; Chen S; Yu S; Qin J; Zhang J; Cheng Q; Ke K; Ding F
Neuropharmacology; 2016 Sep; 108():238-51. PubMed ID: 27108097
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic efficacy of glial cell-derived neurotrophic factor loaded collagen scaffolds in ex vivo organotypic brain slice Parkinson's disease models.
Ucar B; Humpel C
Brain Res Bull; 2019 Jul; 149():86-95. PubMed ID: 31004735
[TBL] [Abstract][Full Text] [Related]
4. Cytoprotective effects of growth factors: BDNF more potent than GDNF in an organotypic culture model of Parkinson's disease.
Stahl K; Mylonakou MN; Skare Ø; Amiry-Moghaddam M; Torp R
Brain Res; 2011 Mar; 1378():105-18. PubMed ID: 21236244
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of growth/differentiation factor 5 and glial cell line-derived neurotrophic factor on dopaminergic neurons and astroglia in cultures of embryonic rat midbrain.
Wood TK; McDermott KW; Sullivan AM
J Neurosci Res; 2005 Jun; 80(6):759-66. PubMed ID: 15880784
[TBL] [Abstract][Full Text] [Related]
6. Effects of combined BDNF and GDNF treatment on cultured dopaminergic midbrain neurons.
Sautter J; Meyer M; Spenger C; Seiler RW; Widmer HR
Neuroreport; 1998 Apr; 9(6):1093-6. PubMed ID: 9601674
[TBL] [Abstract][Full Text] [Related]
7. Effects of glial cell line-derived neurotrophic factor (GDNF) on dopaminergic neurons require concurrent activation of cAMP-dependent signaling pathways.
Engele J; Franke B
Cell Tissue Res; 1996 Nov; 286(2):235-40. PubMed ID: 8854892
[TBL] [Abstract][Full Text] [Related]
8. N-Acetyl Cysteine May Support Dopamine Neurons in Parkinson's Disease: Preliminary Clinical and Cell Line Data.
Monti DA; Zabrecky G; Kremens D; Liang TW; Wintering NA; Cai J; Wei X; Bazzan AJ; Zhong L; Bowen B; Intenzo CM; Iacovitti L; Newberg AB
PLoS One; 2016; 11(6):e0157602. PubMed ID: 27309537
[TBL] [Abstract][Full Text] [Related]
9. Pigment epithelium derived factor (PEDF) is neuroprotective in two in vitro models of Parkinson's disease.
Falk T; Zhang S; Sherman SJ
Neurosci Lett; 2009 Jul; 458(2):49-52. PubMed ID: 19442875
[TBL] [Abstract][Full Text] [Related]
10. Protection of cultured dopamine neurons from MPP(+) requires a combination of neurotrophic factors.
Jaumotte JD; Wyrostek SL; Zigmond MJ
Eur J Neurosci; 2016 Jul; 44(1):1691-9. PubMed ID: 27098376
[TBL] [Abstract][Full Text] [Related]
11. Human dental pulp stem cells protect mouse dopaminergic neurons against MPP+ or rotenone.
Nesti C; Pardini C; Barachini S; D'Alessandro D; Siciliano G; Murri L; Petrini M; Vaglini F
Brain Res; 2011 Jan; 1367():94-102. PubMed ID: 20854799
[TBL] [Abstract][Full Text] [Related]
12. Pitx3-transfected astrocytes secrete brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor and protect dopamine neurons in mesencephalon cultures.
Yang D; Peng C; Li X; Fan X; Li L; Ming M; Chen S; Le W
J Neurosci Res; 2008 Nov; 86(15):3393-400. PubMed ID: 18646205
[TBL] [Abstract][Full Text] [Related]
13. BDNF mediates the neuroprotective effects of positive AMPA receptor modulators against MPP+-induced toxicity in cultured hippocampal and mesencephalic slices.
Jourdi H; Hamo L; Oka T; Seegan A; Baudry M
Neuropharmacology; 2009 Apr; 56(5):876-85. PubMed ID: 19371576
[TBL] [Abstract][Full Text] [Related]
14. Fetal striatum- and ventral mesencephalon-derived expanded neurospheres rescue dopaminergic neurons in vitro and the nigro-striatal system in vivo.
Moses D; Drago J; Teper Y; Gantois I; Finkelstein DI; Horne MK
Neuroscience; 2008 Jun; 154(2):606-20. PubMed ID: 18472226
[TBL] [Abstract][Full Text] [Related]
15. Glial cell line-derived neurotrophic factor stimulates the morphological differentiation of cultured ventral mesencephalic calbindin- and calretinin-expressing neurons.
Widmer HR; Schaller B; Meyer M; Seiler RW
Exp Neurol; 2000 Jul; 164(1):71-81. PubMed ID: 10877917
[TBL] [Abstract][Full Text] [Related]
16. A non-peptidyl neurotrophic small molecule for midbrain dopaminergic neurons.
Lin LF; Rubin LL; Xu M
J Neurochem; 2004 Jun; 89(6):1387-95. PubMed ID: 15189341
[TBL] [Abstract][Full Text] [Related]
17. A Subpopulation of Dopaminergic Neurons Coexpresses Serotonin in Ventral Mesencephalic Cultures But Not After Intrastriatal Transplantation in a Rat Model of Parkinson's Disease.
Di Santo S; Seiler S; Ducray AD; Meyer M; Widmer HR
Cell Transplant; 2017 Apr; 26(4):679-691. PubMed ID: 27938488
[TBL] [Abstract][Full Text] [Related]
18. In vitro regulated expression of tyrosine hydroxylase in ventral midbrain neurons from Nurr1-null mouse pups.
Eells JB; Rives JE; Yeung SK; Nikodem VM
J Neurosci Res; 2001 May; 64(4):322-30. PubMed ID: 11340638
[TBL] [Abstract][Full Text] [Related]
19. Neurotrophic and neuroprotective effects of the neuregulin glial growth factor-2 on dopaminergic neurons in rat primary midbrain cultures.
Zhang L; Fletcher-Turner A; Marchionni MA; Apparsundaram S; Lundgren KH; Yurek DM; Seroogy KB
J Neurochem; 2004 Dec; 91(6):1358-68. PubMed ID: 15584912
[TBL] [Abstract][Full Text] [Related]
20. Influence of time in culture and BDNF pretreatment on survival and function of grafted embryonic rat ventral mesencephalon in the 6-OHDA rat model of Parkinson's disease.
Höglinger GU; Widmer HR; Spenger C; Meyer M; Seiler RW; Oertel WH; Sautter J
Exp Neurol; 2001 Jan; 167(1):148-57. PubMed ID: 11161602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
